MedTrace Logo

Propranolol Rescue of Prolonged Labor

NCT04299438 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2023-08-23

Study results available
· View outcomes & findings →

Summary

A double-blind placebo controlled randomized trial comparing cesarean delivery rates in women given IV propranolol versus placebo for treatment of prolonged labor.

Conditions

  • Pregnancy, Prolonged

Interventions

DRUG

Propranolol Hydrochloride

2mg/mL vials

OTHER

Saline

0.9% saline in vials matching the vials of the active drug

Sponsors & Collaborators

  • Lisa Levine

    lead OTHER

Principal Investigators

  • Lisa Levine, MD, MSCE · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-14
Primary Completion
2022-06-15
Completion
2022-07-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04299438 on ClinicalTrials.gov